trikafta v2
trikafta v2
5 Nov
Advocacy

November Advocacy Update

5 November 2020

Trikafta

CFNZ is continuing to work closely with Trikafta for Kiwis to secure approval of Trikafta as soon as possible. Having Trikafta publicly funded in New Zealand would bring life-changing benefits for many Kiwis with cystic fibrosis and we can’t afford to wait any longer for this medicine.  If you haven’t already done so, please sign the Trikafta petition here to make it loud and clear that Kiwis need Trikafta now. 

Medicines Funding

CFNZ is also working to change to the way medicine are funded in New Zealand. The current Pharmac  model isn’t working and is costing lives. Pharmac urgently needs more money to clear the growing backlog of medicines awaiting funding, and provide for new medicines.While CFNZ also supports a review of Pharmac in the longer term, a major funding increase is needed now to enable New Zealand to catch up with Australia and other developed countries.  If you haven’t already done so, please sign the Patient Voice Aotearoa petition here to voice your support for urgent change to medicines funding in New Zealand.

CFNZ will shortly be writing to the new Minister of Health and MPs to raise these issues and seek their full commitment to making changes to save Kiwi lives.